Loading...

New-onset graves’ disease after the initiation of nivolumab therapy for gastric cancer: a case report

BACKGROUND: Immune checkpoint inhibitors (ICIs) can induce immune-related adverse events (irAEs) including thyroid dysfunction. There are only a few reports on Graves’ disease induced by ICIs. We report a case of new-onset Graves’ disease after the initiation of nivolumab therapy in a patient receiv...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Endocr Disord
Main Authors: Yamada, Hiroshi, Okajima, Fumitaka, Onda, Takeshi, Fujimori, Shunji, Emoto, Naoya, Sugihara, Hitoshi
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7449083/
https://ncbi.nlm.nih.gov/pubmed/32847555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-020-00613-5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!